Applied DNA Sciences (APDN.US): The 2024 Q2 earnings report achieved revenue of $929,63 million, with a previous value of $4.408 million and an expected value of $950,000; earnings per share were -2.71 dollars, previous value of -0.20 dollars, and expected value of -4.50 dollars.
Applied DNA Sciences(APDN.US)：2024年Q2财报实现营收92.963万美元，前值为440.8万美元，预期值为95万美元；每股收益为-2.71美元，前值为-0.20美元，预期值为-4.50美元。
Applied DNA Sciences (APDN.US): The 2024 Q2 earnings report achieved revenue of $929,63 million, with a previous value of $4.408 million and an expected value of $950,000; earnings per share were -2.71 dollars, previous value of -0.20 dollars, and expecte
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.